Prosight Management, LP Charles River Laboratories International, Inc. Transaction History

Prosight Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $1.04 Million - $1.43 Million	5,720 Added 20.8%	33,220 $6.54 Million
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $816,520 - $1.21 Million	-4,000 Reduced 12.7%	27,500 $5.88 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $4.09 Million - $5.8 Million	16,019 Added 103.48%	31,500 $8.95 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $5.44 Million - $6.95 Million	15,481 New	15,481 $5.83 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.